Friday 6 November 2026
Export FOCL’s income statement to Excel — free account
FocalTherics
FOCL Healthcare Medical Distribution
- Revenue
- +38.9%
- EPS
- −129.4%
- Free cash flow
- +21.5%
- Total debt
- +366.8%
Quarter to June 2026, against a year earlier
3.87
0.38
−8.94%
Follow FOCL
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.00% | (61.02%) | (83.79%) | (133.48%) | |
Piotroski F-Score |
4 | 3 | 3 | 4 | |
| (27.10%) | (34.73%) | (40.37%) | (50.28%) | ||
ROIC |
(64.11%) | (71.99%) | (81.16%) | (110.75%) | |
Return on Tangible Assets |
(80.56%) | (101.51%) | (133.93%) | (126.51%) | |
Average Days of Receivables |
131.89 | 84.02 | 100.17 | 50.27 | |
Free Cash Flow per Share |
(0.48) | (0.62) | (0.56) | (0.51) | |
Free Cash Flow |
(17.79) | (23.19) | (20.87) | (19.13) | |
Capital Expenditures |
(3.75) | (6.78) | (6.83) | (6.10) | |
| Other line items | |||||
Cash ROIC |
(37.95%) | (37.19%) | (41.86%) | (32.75%) | |
Accounts Receivable Turnover |
3.06 | 3.78 | 3.92 | 4.78 | |
Accounts Payable Turnover |
1.68 | 3.55 | 2.68 | 2.68 | |
Inventory Turnover |
1.73 | 3.00 | 2.56 | 3.25 | |
Average Days of Payables |
211.03 | 87.92 | 109.15 | 87.55 | |
Days of Inventory on Hand |
172.90 | 69.98 | 116.09 | 69.82 | |
Tax Rate |
0.01 | 0.02 | 0.01 | 0.01 | |
Research and Development Expense of Revenue |
15.06% | 13.70% | 13.06% | 12.47% | |
Selling, General and Administrative Expense of Revenue |
66.26% | 63.85% | 65.11% | 66.98% | |
Share Based Compensation of Revenue |
0.00% | 9.87% | 5.01% | 5.43% | |
Operating CF/Net income |
0.65 | 0.56 | 0.45 | 0.33 | |
Depreciation/Fixed assets |
0.00 | 0.89 | 0.58 | 0.71 | |
Capex/Depreciation |
0.00 | (0.87) | (1.16) | (0.99) | |
Revenue per Share |
1.65 | 1.88 | 1.98 | 2.07 | |
Operating CF per Share |
(0.37) | (0.44) | (0.37) | (0.35) | |
Capex per Share |
(0.10) | (0.18) | (0.18) | (0.16) | |
Capex to Sales |
0.06 | 0.10 | 0.09 | 0.08 |
Columns are period end dates · fundamentals updated 26 Oct 2026